🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I recently found out I'm going to be a father. Here are the principles I want to teach my child to live by:

Updating his 2015 update of the MAC-NPC from The Lancet Oncology. Great job Pierre Blanchard, MD et al! Addition of chemo to RT reduced risk of death with an absol survival increase 8.4% at 10yrs. Largest effect observed for CRT+adjuvant, induction+CRT, & CRT. HR 0.68, 0.73, 0.81 #radonc

How can PET help clarify disease extent in #meningioma? En route to DC #ASTRO24 ASTRO to share our experience Weill Cornell Medicine Radiology WCM Molecular Imaging and Therapeutics with #radonc friends - hope to see many of you there, 9/30, room202, 3pm Sabin Motwani Joshua D. Palmer, MD RaleighLab gelareh-zadeh

Just a few hours away! Join me as I moderate EDU 29: Emerging Diagnostic and Therapeutic Options for Meningioma. Room 202 Excited to share the stage with RaleighLab Jana Ivanidze gelareh-zadeh Joshua D. Palmer, MD #ASTRO24 #meningioma #btsm

Presented at #SABCS24: The INSEMA randomized trial involving patients with clinically node-negative, T1 breast cancer showed that the omission of axillary surgery was noninferior to sentinel-lymph-node biopsy. Full trial results: nej.md/41o5L0Z

Presented at #SABCS24: Interim results from the EUROPA trial: Single-modality #endocrinetherapy vs #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #breastcancer thelancet.com/journals/lanon…

Congratulations to Rutgers Cancer Institute RWJBarnabas Dr. Rahul Parikh Rahul R. Parikh, MD, MBA and Dr. Sabin Motwani @sabinmotwanimd for being selected as Fellows of the American Society for Radiation Oncology (FASTRO) ASTRO! They will be recognized at ASTRO’s 67th Annual Meeting on Tues, 9/30.

Honored to have had our conference room in our new cancer center ⁦Rutgers Radiation Oncology Residency Program⁩ dedicated. After 20 years ⁦Rutgers Cancer Institute⁩ stepping down as chair but staying on for an exciting new era. ⁦Bruce Haffty⁩